Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Dec 31, 2025 | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 6.6B | 5.6B | 6.4B | 9.9B | -- |
| Operating Revenue | 6.6B | 5.6B | 6.4B | 9.9B | -- |
| Cost Of Revenue | 3.2B | 2.9B | 3.2B | 4.3B | -- |
| Gross Profit | 3.4B | 2.7B | 3.2B | 5.5B | -- |
| Selling General And Administration | 175.6M | 248.1M | 212.2M | 213.2M | -- |
| General And Administrative Expense | 175.6M | 248.1M | 212.2M | 213.2M | -- |
| Other Operating Expenses | 1.4B | 1.3B | 1.2B | 1.3B | -- |
| Operating Expense | 1.6B | 1.5B | 1.5B | 1.5B | -- |
| Operating Income | 1.8B | 1.2B | 1.7B | 4.0B | -- |
| EBIT | 1.8B | 1.6B | 2.2B | 3.1B | -- |
| Interest Expense | 151.3M | 133.8M | 105.5M | 97.2M | -- |
| Interest Expense Non Operating | 151.3M | 133.8M | 105.5M | 97.2M | -- |
| Interest Income | 20.4M | 20.2M | 12.3M | 18.1M | -- |
| Interest Income Non Operating | 20.4M | 20.2M | 12.3M | 18.1M | -- |
| Net Interest Income | -130.9M | -113.6M | -93.2M | -79.1M | -- |
| Other Income Expense | 1.7M | 349.1M | 435.5M | -969.6M | -- |
| Other Non Operating Income Expenses | -- | -- | -- | -- | 15.6M |
| Special Income Charges | 6.8M | 77.7M | 91.7M | -4.7M | -- |
| Restructuring And Mergern Acquisition | -- | -- | -- | 0.00 | 22.1M |
| Write Off | -2.8M | 2.3M | -7.3M | 6.7M | -- |
| Gain On Sale Of Security | -5.1M | 271.4M | 343.8M | -964.9M | -- |
| Pretax Income | 1.6B | 1.5B | 2.1B | 3.0B | -- |
| Tax Provision | 358.8M | 330.9M | 460.8M | 675.9M | -- |
| Tax Effect Of Unusual Items | 373,315 | 79.4M | 97.5M | -220.0M | -- |
| Net Income From Continuing And Discontinued Operation | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Net Income From Continuing Operation Net Minority Interest | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Net Income Including Noncontrolling Interests | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Net Income Common Stockholders | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Net Income | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| EBITDA | 3.3B | 2.9B | 3.6B | 4.4B | -- |
| Normalized EBITDA | 3.3B | 2.6B | 3.1B | 5.4B | -- |
| Reconciled Depreciation | 1.5B | 1.4B | 1.4B | 1.3B | -- |
| Basic EPS | 2.19 | 1.89 | 2.62 | 3.48 | -- |
| Diluted EPS | 2.19 | 1.88 | 2.61 | 3.47 | -- |
| Basic Average Shares | 582.2M | 594.9M | 609.4M | 661.2M | -- |
| Diluted Average Shares | 582.6M | 596.4M | 610.6M | 663.1M | -- |
| Total Unusual Items | 1.7M | 349.1M | 435.5M | -969.6M | -- |
| Total Unusual Items Excluding Goodwill | 1.7M | 349.1M | 435.5M | -969.6M | -- |
| Tax Rate For Calcs | 0.22 | 0.23 | 0.22 | 0.23 | -- |
| Normalized Income | 1.3B | 854.4M | 1.3B | 3.1B | -- |
| Diluted NI Availto Com Stockholders | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Gain On Sale Of Ppe | 4.0M | 80.0M | 84.4M | 2.0M | -- |
| Impairment Of Capital Assets | -- | -- | -- | -3.6M | -137.5M |
| Net Income Continuous Operations | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Net Non Operating Interest Income Expense | -130.9M | -113.6M | -93.2M | -79.1M | -- |
| Other Gand A | 175.6M | 248.1M | 212.2M | 213.2M | -- |
| Reconciled Cost Of Revenue | 3.2B | 2.9B | 3.2B | 4.3B | -- |
| Total Expenses | 4.8B | 4.4B | 4.6B | 5.8B | -- |
| Line Item | FY 2025Dec 31, 2025 | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 7.0M | 0.00 | 1.1M | 57.1M | -- |
| Cash Cash Equivalents And Short Term Investments | 7.0M | 0.00 | 1.1M | 57.1M | -- |
| Accounts Receivable | 749.2M | 691.0M | 583.0M | 863.2M | -- |
| Receivables | 749.2M | 691.0M | 583.0M | 863.2M | -- |
| Inventory | 17.9M | 12.4M | 29.1M | 6.7M | -- |
| Prepaid Assets | 136.6M | 107.4M | 102.7M | 52.5M | -- |
| Current Assets | 1.0B | 1.0B | 893.4M | 986.5M | -- |
| Gross PPE | 24.6B | 20.8B | 18.9B | 16.8B | -- |
| Accumulated Depreciation | -10.7B | -9.1B | -7.7B | -6.4B | -- |
| Net PPE | 13.9B | 11.7B | 11.2B | 10.4B | -- |
| Goodwill | 248.2M | 248.2M | 248.2M | 248.2M | -- |
| Goodwill And Other Intangible Assets | 248.2M | 248.2M | 248.2M | 248.2M | -- |
| Investments And Advances | 30.2M | 27.7M | 19.7M | 14.5M | -- |
| Total Non Current Assets | 14.3B | 12.1B | 11.5B | 10.6B | -- |
| Total Assets | 15.3B | 13.1B | 12.4B | 11.6B | -- |
| Current Debt | 450.0M | -- | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 562.1M | 92.8M | 85.2M | 92.4M | -- |
| Accounts Payable | 760.8M | 634.4M | 753.3M | 1.2B | -- |
| Payables | 880.8M | 746.6M | 855.0M | 1.3B | -- |
| Payables And Accrued Expenses | 880.8M | 746.6M | 855.0M | 1.3B | -- |
| Other Current Liabilities | -- | 1.0M | 3.6M | 303.0M | 465.3M |
| Current Liabilities | 1.5B | 880.7M | 981.6M | 1.7B | -- |
| Long Term Debt | 2.4B | 1.4B | 1.1B | 990.0M | -- |
| Long Term Debt And Capital Lease Obligation | 3.4B | 2.3B | 2.1B | 1.7B | -- |
| Long Term Capital Lease Obligation | 922.1M | 908.5M | 974.6M | 702.9M | -- |
| Total Non Current Liabilities Net Minority Interest | 5.6B | 4.3B | 4.0B | 3.3B | -- |
| Total Liabilities Net Minority Interest | 7.0B | 5.2B | 5.0B | 5.0B | -- |
| Common Stock | 6.0B | 6.2B | 6.3B | 6.5B | -- |
| Capital Stock | 6.0B | 6.2B | 6.3B | 6.5B | -- |
| Additional Paid In Capital | 28.4M | 31.6M | 36.1M | 39.9M | -- |
| Retained Earnings | 2.2B | 1.7B | 1.1B | 139.1M | -- |
| Gains Losses Not Affecting Retained Earnings | -2.0M | -6.2M | -17.9M | -23.1M | -- |
| Other Equity Adjustments | -2.0M | -6.2M | -17.9M | -23.1M | -- |
| Common Stock Equity | 8.3B | 7.9B | 7.4B | 6.7B | -- |
| Stockholders Equity | 8.3B | 7.9B | 7.4B | 6.7B | -- |
| Total Equity Gross Minority Interest | 8.3B | 7.9B | 7.4B | 6.7B | -- |
| Total Capitalization | 10.7B | 9.3B | 8.6B | 7.6B | -- |
| Net Tangible Assets | 8.0B | 7.7B | 7.2B | 6.4B | -- |
| Tangible Book Value | 8.0B | 7.7B | 7.2B | 6.4B | -- |
| Working Capital | -445.2M | 120.2M | -88.2M | -729.2M | -- |
| Invested Capital | 11.1B | 9.3B | 8.6B | 7.6B | -- |
| Total Debt | 3.9B | 2.4B | 2.2B | 1.8B | -- |
| Net Debt | 2.9B | 1.4B | 1.1B | 932.9M | -- |
| Share Issued | 570.6M | 589.6M | 596.9M | 620.9M | -- |
| Ordinary Shares Number | 570.6M | 589.6M | 596.9M | 620.9M | -- |
| Accrued Interest Receivable | -- | -- | -- | -- | 37.2M |
| Allowance For Doubtful Accounts Receivable | -4.1M | -6.9M | -4.6M | -12.7M | -- |
| Assets Held For Sale Current | -- | -- | 0.00 | 6.1M | 0.00 |
| Buildings And Improvements | 38.7M | 40.2M | 40.2M | 41.4M | -- |
| Capital Lease Obligations | 1.0B | 1.0B | 1.1B | 795.3M | -- |
| Current Capital Lease Obligation | 112.1M | 92.8M | 85.2M | 92.4M | -- |
| Current Deferred Liabilities | 28.6M | 23.3M | 20.8M | 20.0M | -- |
| Current Provisions | 20.0M | 17.0M | 17.0M | 16.0M | -- |
| Derivative Product Liabilities | 138.9M | 37.1M | 10.5M | 38.1M | -- |
| Dividends Payable | 120.0M | 112.2M | 101.7M | 93.4M | -- |
| Duefrom Related Parties Current | -- | -- | 4.2M | 3.7M | 37.2M |
| Employee Benefits | 28.1M | 76.2M | 58.4M | 48.1M | -- |
| Financial Assets | 56.4M | 154.1M | 61.5M | 13.3M | -- |
| Gross Accounts Receivable | 753.3M | 697.9M | 587.6M | 875.9M | -- |
| Hedging Assets Current | 135.6M | 190.1M | 177.5M | 900,000 | -- |
| Long Term Provisions | 473.9M | 414.4M | 434.3M | 378.3M | -- |
| Machinery Furniture Equipment | 1.2B | 1.2B | 1.2B | 868.1M | -- |
| Non Current Deferred Liabilities | 1.6B | 1.4B | 1.3B | 1.1B | -- |
| Non Current Deferred Taxes Liabilities | 1.5B | 1.4B | 1.2B | 961.6M | -- |
| Other Current Borrowings | 450.0M | -- | -- | -- | -- |
| Other Properties | 422.9M | 306.2M | 228.4M | 173.9M | -- |
| Other Receivables | -- | -- | 78.0M | 24.2M | -- |
| Line Item | FY 2025Dec 31, 2025 | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | 3.1B | 2.3B | 2.4B | 3.8B | -- |
| Cash Flow From Continuing Operating Activities | 3.1B | 2.3B | 2.4B | 3.8B | -- |
| Depreciation Amortization Depletion | 1.5B | 1.4B | 1.4B | 1.3B | -- |
| Stock Based Compensation | 700,000 | 1.0M | 1.2M | 1.2M | -- |
| Deferred Tax | 98.8M | 130.5M | 259.3M | 387.4M | -- |
| Deferred Income Tax | 98.8M | 130.5M | 259.3M | 387.4M | -- |
| Change In Working Capital | -98.9M | -123.9M | -245.3M | 120.8M | -- |
| Change In Payables And Accrued Expense | -- | -- | -- | -- | 100,000 |
| Change In Other Working Capital | -3.5M | -104.0M | -236.0M | 250.0M | -- |
| Change In Other Current Liabilities | -95.4M | -19.9M | -9.3M | -129.2M | -- |
| Other Non Cash Items | 20.8M | 11.5M | 17.6M | 12.5M | -- |
| Capital Expenditure | -1.9B | -1.8B | -1.8B | -1.4B | -- |
| Purchase Of PPE | -71.4M | -45.1M | -500,000 | -2.7M | -- |
| Net PPE Purchase And Sale | -67.4M | 34.9M | 117.3M | 9.2M | -- |
| Purchase Of Business | -1.7B | 0.00 | -- | -- | -- |
| Sale Of Business | -- | -- | -- | 0.00 | 4.9M |
| Purchase Of Investment | -- | -- | -5.4M | -12.0M | -2.5M |
| Net Investment Purchase And Sale | -3.5M | -6.8M | -5.4M | -12.0M | -- |
| Investing Cash Flow | -3.5B | -1.9B | -1.7B | -1.4B | -- |
| Cash Flow From Continuing Investing Activities | -3.5B | -1.9B | -1.7B | -1.4B | -- |
| Issuance Of Debt | 7.6B | 7.3B | 4.2B | 7.0B | -- |
| Repayment Of Debt | -6.2B | -7.2B | -4.2B | -7.8B | -- |
| Net Issuance Payments Of Debt | 1.4B | 143.4M | 85.1M | -805.8M | -- |
| Repurchase Of Capital Stock | -514.0M | -202.4M | -469.3M | -1.3B | -- |
| Net Common Stock Issuance | -514.0M | -202.4M | -469.3M | -1.3B | -- |
| Common Stock Dividend Paid | -444.0M | -405.7M | -392.0M | -294.3M | -- |
| Common Stock Payments | -514.0M | -202.4M | -469.3M | -1.3B | -- |
| Financing Cash Flow | 449.5M | -443.5M | -759.6M | -2.4B | -- |
| Cash Flow From Continuing Financing Activities | 449.5M | -443.5M | -759.6M | -2.4B | -- |
| Changes In Cash | 7.0M | -1.1M | -56.0M | 57.1M | -- |
| Beginning Cash Position | 0.00 | 1.1M | 57.1M | 0.00 | -- |
| End Cash Position | 7.0M | 0.00 | 1.1M | 57.1M | -- |
| Free Cash Flow | 1.2B | 515.7M | 556.0M | 2.4B | -- |
| Income Tax Paid Supplemental Data | 183.3M | 199.7M | 510.2M | -- | 56.9M |
| Interest Paid Supplemental Data | 129.5M | 117.4M | 88.1M | 82.8M | -- |
| Asset Impairment Charge | -2.8M | 2.3M | -7.3M | 6.7M | -- |
| Capital Expenditure Reported | -1.8B | -1.8B | -1.8B | -1.4B | -- |
| Cash Dividends Paid | -444.0M | -405.7M | -392.0M | -294.3M | -- |
| Change In Accrued Expense | -- | -- | -- | -- | 100,000 |
| Change In Interest Payable | -- | -- | -- | -- | 100,000 |
| Depletion | 1.5B | 1.4B | 1.4B | 1.3B | -- |
| Gain Loss On Investment Securities | 253.3M | -82.7M | -556.2M | -280.5M | -- |
| Gain Loss On Sale Of PPE | -4.0M | -80.0M | -84.4M | -2.0M | -- |
| Long Term Debt Issuance | 7.6B | 7.3B | 4.2B | 7.0B | -- |
| Long Term Debt Payments | -6.2B | -7.2B | -4.2B | -7.8B | -- |
| Net Business Purchase And Sale | -1.7B | 0.00 | -- | 0.00 | 4.9M |
| Net Foreign Currency Exchange Gain Loss | 3.3M | 5.1M | 7.1M | -28.8M | -- |
| Net Income From Continuing Operations | 1.3B | 1.1B | 1.6B | 2.3B | -- |
| Net Long Term Debt Issuance | 1.4B | 143.4M | 85.1M | -805.8M | -- |
| Net Other Financing Charges | 4.9M | 4.7M | -- | -- | -- |
| Net Other Investing Changes | 26.1M | -146.5M | 35.2M | 15.7M | -- |
| Operating Gains Losses | 252.6M | -157.6M | -633.5M | -311.3M | -- |
| Proceeds From Stock Option Exercised | 10.4M | 16.5M | 16.6M | 29.4M | -- |
| Sale Of PPE | 4.0M | 80.0M | 117.8M | 11.9M | -- |
| Unrealized Gain Loss On Investment Securities | -- | -- | -- | -- | 534.2M |